Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1983 Oct;42(5):558–562. doi: 10.1136/ard.42.5.558

Leucocyte superoxide dismutase in rheumatoid arthritis.

A A Youssef, D N Baron
PMCID: PMC1001296  PMID: 6625704

Abstract

Superoxide dismutase (SOD) activity was measured in polymorphonuclear leucocytes (PMNLs) and mononuclear cells (MNCs) from 60 patients with rheumatoid arthritis (RA) and in 15 controls. In all patients and controls SOD activity (U/mg protein) in MNCs was twice that in PMNLs. SOD activity in PMNLs and in MNCs from patients with RA was significantly higher than that in controls. SOD activity in PMNLs (but not in MNCs) from patients treated with corticosteroids was significantly higher than that from patients treated with nonsteroidal anti-inflammatory drugs. There was no relation between SOD activity in both PMNLs and MNCs and either the patients' age, sex, duration of disease, serum immunoglobulin concentration, IgM rheumatoid factor, and copper level, or the degree of disease activity.

Full text

PDF
558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babior B. M., Kipnes R. S., Curnutte J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973 Mar;52(3):741–744. doi: 10.1172/JCI107236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baron D. N., Ahmed S. A. Intracellular concentrations of water and of the principal electrolytes determined by analysis of isolated human leucocytes. Clin Sci. 1969 Aug;37(1):205–219. [PubMed] [Google Scholar]
  3. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971 Nov;44(1):276–287. doi: 10.1016/0003-2697(71)90370-8. [DOI] [PubMed] [Google Scholar]
  4. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  5. Davies A. J. The thymus and the cellular basis of immunity. Transplant Rev. 1969;1:43–91. doi: 10.1111/j.1600-065x.1969.tb00136.x. [DOI] [PubMed] [Google Scholar]
  6. DeChatelet L. R., McCall C. E., McPhail L. C., Johnston R. B., Jr Superoxide dismutase activity in leukocytes. J Clin Invest. 1974 Apr;53(4):1197–1201. doi: 10.1172/JCI107659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glasser L., Huestis D. W., Jones J. F. Functional capabilities of steroid-recruited neutrophils harvested for clinical transfusion. N Engl J Med. 1977 Nov 10;297(19):1033–1036. doi: 10.1056/NEJM197711102971904. [DOI] [PubMed] [Google Scholar]
  8. Gregory E. M., Fridovich I. Induction of superoxide dismutase by molecular oxygen. J Bacteriol. 1973 May;114(2):543–548. doi: 10.1128/jb.114.2.543-548.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hassan H. M., Fridovich I. Regulation of the synthesis of superoxide dismutase in Escherichia coli. Induction by methyl viologen. J Biol Chem. 1977 Nov 10;252(21):7667–7672. [PubMed] [Google Scholar]
  10. Jessop J. D., Vernon-Roberts B., Harris J. Effects of gold salts and prednisolone on inflammatory cells. I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a "skin-window" technique in rheumatoid and control patients. Ann Rheum Dis. 1973 Jul;32(4):294–300. doi: 10.1136/ard.32.4.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnston R. B., Jr, Keele B. B., Jr, Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., RaJagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest. 1975 Jun;55(6):1357–1372. doi: 10.1172/JCI108055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnston R. B., Jr, Lehmeyer J. E. Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease. J Clin Invest. 1976 Apr;57(4):836–841. doi: 10.1172/JCI108359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kobayashi Y., Ishigame K., Ishigame Y., Usui T. Superoxide dismutase activity of human granulocytes and lymphocytes. Lancet. 1977 Apr 16;1(8016):865–866. doi: 10.1016/s0140-6736(77)92823-9. [DOI] [PubMed] [Google Scholar]
  14. Kobayashi Y., Okahata S., Sakano T., Tanabe K., Usui T. Superoxide dismutase activity of T lymphocytes and non-T lymphocytes. FEBS Lett. 1979 Feb 15;98(2):391–393. doi: 10.1016/0014-5793(79)80224-0. [DOI] [PubMed] [Google Scholar]
  15. Kuntzman R., Lawrence D., Conney A. H. Michaelis constants for the hydroxylation of steroid hormones and drugs by rat liver microsomes. Mol Pharmacol. 1965 Sep;1(2):163–167. [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Lunec J., Dormandy T. L. Fluorescent lipid-peroxidation products in synovial fluid. Clin Sci (Lond) 1979 Jan;56(1):53–59. doi: 10.1042/cs0560053. [DOI] [PubMed] [Google Scholar]
  18. Mauer A. M., Athens J. W., Ashenbrucker H., Cartwright G. E., Wintrobe M. M. LEUKOKINETIC STUDIES. II. A METHOD FOR LABELING GRANULOCYTES IN VITRO WITH RADIOACTIVE DIISOPROPYLFLUOROPHOSPHATE (DFP). J Clin Invest. 1960 Sep;39(9):1481–1486. doi: 10.1172/JCI104167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McCord J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974 Aug 9;185(4150):529–531. doi: 10.1126/science.185.4150.529. [DOI] [PubMed] [Google Scholar]
  20. McCord J. M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969 Nov 25;244(22):6049–6055. [PubMed] [Google Scholar]
  21. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  22. Nelson D. H., Ruhmann-Wennhold A. Inhibition of leukocyte superoxide anion production by cortisol administration to normal subjects. J Clin Endocrinol Metab. 1978 Apr;46(4):702–705. doi: 10.1210/jcem-46-4-702. [DOI] [PubMed] [Google Scholar]
  23. Puig-Parellada P., Planas J. M. Synovial fluid degradation induced by free radicals. In vitro action of several free radical scavengers and anti-inflammatory drugs. Biochem Pharmacol. 1978 Feb 15;27(4):535–537. doi: 10.1016/0006-2952(78)90390-8. [DOI] [PubMed] [Google Scholar]
  24. Salin M. L., McCord J. M. Superoxide dismutases in polymorphonuclear leukocytes. J Clin Invest. 1974 Oct;54(4):1005–1009. doi: 10.1172/JCI107816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shohet S. B., Pitt J., Baehner R. L., Poplack D. G. Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun. 1974 Dec;10(6):1321–1328. doi: 10.1128/iai.10.6.1321-1328.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WILSON D. L., MANERY J. F. The permeability of rabbit leucocytes to sodium, potassium and chloride. J Cell Physiol. 1949 Dec;34(3):493–519. doi: 10.1002/jcp.1030340312. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES